Select Your Region
Americas
Europe
Africa
Global
Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- GARDENIA
A Clinical Trial to Compare Etrolizumab with Infliximab in Patients with Moderate to Severe Ulcerative Colitis Who Have not Received Treatment with Tumour Necrosis Factor Inhibitors (Gardenia)
A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors
Autoimmune Disorder Inflammatory Bowel Disease (IBD) Ulcerative Colitis
Study results
LPS_GA29103_GARDENIA_interim results_October2021_English
(PDF, 0.7 MB)
LPS_GA29103_GARDENIA_final results_20Oct2021_English_cs
(PDF, 0.4 MB)
LPS_GA29103_GARDENIA_final results_20Oct2021_English_de(at)
(PDF, 0.3 MB)
LPS_GA29103_GARDENIA_final results_20Oct2021_English_de(de)
(PDF, 0.4 MB)
LPS_GA29103_GARDENIA_final results_20Oct2021_English_es
(PDF, 0.3 MB)
LPS_GA29103_GARDENIA_final results_20Oct2021_English_fr(ca)
(PDF, 0.3 MB)
LPS_GA29103_GARDENIA_final results_20Oct2021_English_he
(PDF, 0.3 MB)
LPS_GA29103_GARDENIA_final results_20Oct2021_English_hu
(PDF, 0.4 MB)
LPS_GA29103_GARDENIA_final results_20Oct2021_English_it
(PDF, 0.4 MB)
LPS_GA29103_GARDENIA_final results_20Oct2021_English_ko
(PDF, 0.6 MB)
LPS_GA29103_GARDENIA_final results_20Oct2021_English_nl(be)
(PDF, 0.4 MB)
LPS_GA29103_GARDENIA_final results_20Oct2021_English_nl(nl)
(PDF, 0.4 MB)
LPS_GA29103_GARDENIA_final results_20Oct2021_English_no
(PDF, 0.4 MB)
LPS_GA29103_GARDENIA_final results_20Oct2021_English_pt
(PDF, 0.4 MB)
LPS_GA29103_GARDENIA_final results_20Oct2021_English_ro
(PDF, 0.3 MB)
LPS_GA29103_GARDENIA_final results_20Oct2021_English_sv(se)
(PDF, 0.4 MB)
LPS_GA29103_GARDENIA_final results_20Oct2021_English_fr(fr).pdf
(PDF, 0.4 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com